| 1Hanash S.Disease proteomics[R].Nature JT-Nature,2003,422(6928):226-232.
2Adkins JN,Varnum SM,Auberry KJ,et a1.Toward a human blood serum pro-teome:analysis by multi-dimensional separation coupled with mass spectrometry[J].Mol Cell Proteomics,2002,1(12):947-55.
3Wong TS,Kwong DL,Sham J,et al.Elevation of plasma osteopontin level in pa-tients with undifferentiated nasopharyngeal carcinoma[J].Eur J Oncol,2005,31(5):555-558.
4程钢,邵建永,何蕴韶,等.鼻咽癌外周血免疫指标研究[J].第一军医大学学报,2002,22(12):1104-1105.
5Tan EL,Selvaratnam G,Kananathan R,et al.Quantification of epstein-barr virus DNA load,interleukin-6,inter-leukin-10,transforming growth factor-β1and stem cell factor in plasma of patients with nasopharyngeal carcinoma[J].BMC Cancer,2006Sep24,6:227.
6Yu Y,Dong W,Zhou X,et al.The significance of serum soluble intercellular adhe-sion molecule and transforming growth factor alpha in patients with nasopharyngeal carcinoma[J].Arch Otolaryngol Head Neck Surg,2004,130(10):1205-1208.
7BrahamH,Trimeche M,Ziadi S,etal.CD10expression by fusiformstromal cells in nasopharyngeal carcinoma correlates with tumor progression[J].Virchows Arch,2006,449(2):220-224.
8Chang CS,Chang JH,Hsu NC,et al.Expression of CD80and CD86costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma[J].BMC Cancer,2007May24,7:88.
9Chen CL,Ou DL.Expression of syndecan-1(CD138)in nasopharyngeal carcino-ma is correlated with advanced stage and poor prognosis[J].Hum Pathol,2006,37(10):1279-1285.
10Wei YS,Zheng YH,Zhang ZH,et al.Identification of serum biomarkers for naso-pharyngeal carcinoma by proteomic analysis[J].Cancer,2008,12(3):544-551.
11Guo X,Cao SM,Yu JK,et al.Distinct serumal proteomic patterns between as-cending and descending types of locoregionally advanced nasopharyngeal carcino-ma assessed by surface enhanced laser desorption ionization and analyses[J].Chin Med J,2005,118(22):1912-1917.
12Cho WC,Yip TT,Yi PC,et al.Identification ofserum amyloid a pro-tein as a po-tentially usefulbiomarker tomonitor relapse of nasopharyngeal cancer by serum proteomic profiling[J].Clin Cancer Res,2004,10(1Pt1):43-52.
13Huang YJ,Xuan C,Zhang BB,et al.SELDI-TOF-MS profiling of serum for detec-tion of nasopharyngeal carcinoma[J].Cancer,2008Feb1,112(3):544-551.
14Doustjalali SR,Yusof R,Govindasamy GK,et al.Patients with nasopharyngeal carcinoma demonstrate enhanced serumand tissue ceruloplasmin expression[J].J Med Invest,2006Feb,53(1-2):20-28.
15廖秋林,陈晓东,赵亮,等.鼻咽癌血清比较蛋白质组学研究[J].南方医科大学学报,2008,28(2):154-158.
16Liao QL,Zhao L,Chen X,et al.Serum proteome analysis for profiling protein markers associated with carcinogenesis and lymph node metastasis in nasopharyn-geal carcinoma[J].Clinical and Experimental Metastasis,2008,25(4):465-476.
17Vlahou A,Sehellhammer PF,Mendrinos S,et a1.Development of a novel pro-teomic approach for the detection of transitional cell carcinoma of the bladder in urine[J].American Journal of Pathology,2001,158(4):1491-1502.
18马宁,葛春林,栾凤鸣,等.SELDI-TOF-MS技术在胰腺癌诊断中的应用[J].中华外科杂志,2008,46(12):932-935.
19Zhukov TA,Johanson RA,Cantor AB,et al.Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrom-etry[J].Lung Cancer,2003,40(3):267-279.
20刘池波,梁勇,潘春琴,等.SELDI-TOF-MS技术在肝癌诊断中的临床应用性研究[J].中国热带医学,2007,7(1):18-20.
21Grizzle WE,Adam BL,Bigbee WL,et a1.Serum protein expression profiling for cancer detection:validation of a SELDI-based approach for prostate cancer[J].Disease Markers,2003,19(4-5):185-195.
22王雅杰,张锟,吴小易,等.传染性非典型肺炎患者血清蛋白质指纹图谱分析[J].中华检验医学杂志,2005,28(4):381-383.
23王琪,李力,黎丹戎,等.应用飞行时间质谱技术结合蛋白芯片筛选卵巢恶性肿瘤患者的血清标志物[J].中华妇产科杂志,2006,41(8):544-548.
24刘彩刚,路平,赵祥,等.SELDI-TOF-MS筛查乳腺癌患者血清特异性蛋白的探讨[J].中国肿瘤临床,2007,34(13):728-730. |
